{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T23:23:05Z","timestamp":1790032985549,"version":"4.0.1"},"reference-count":31,"publisher":"Japan Neurosurgical Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurol. Med. Chir.(Tokyo)"],"published-print":{"date-parts":[[2025,6,15]]},"DOI":"10.2176\/jns-nmc.2025-0019","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T22:07:57Z","timestamp":1745878077000},"page":"290-295","source":"Crossref","is-referenced-by-count":2,"title":["Association between RNF213 p.R4810K and Progression of Cerebral Artery Negative Remodeling in Moyamoya Disease"],"prefix":"10.2176","volume":"65","author":[{"given":"Haruto","family":"UCHINO","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Hokkaido University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"ITO","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Hokkaido University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taku","family":"SUGIYAMA","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Hokkaido University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kota","family":"KURISU","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Hokkaido University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyuki","family":"FUJIMA","sequence":"additional","affiliation":[{"name":"Department of Radiology, Hokkaido University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miki","family":"FUJIMURA","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Hokkaido University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"971","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1) Suzuki J, Takaku A. Cerebrovascular &quot;moyamoya&quot; disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol. 1969;20 (3):288-99. doi: 10.1001\/archneur.1969.00480090076012","DOI":"10.1001\/archneur.1969.00480090076012"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2) Fujimura M, Tominaga T. Diagnosis of Moyamoya disease: international standard and regional differences. Neurol Med Chir (Tokyo). 2015;55 (3):189-93. doi: 10.2176\/nmc.ra.2014-0307","DOI":"10.2176\/nmc.ra.2014-0307"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3) Fujimura M, Tominaga T, Kuroda S, et al. 2021 Japanese guidelines for the management of Moyamoya disease: guidelines from the research committee on Moyamoya disease and Japan stroke society. Neurol Med Chir (Tokyo). 2022;62 (4):165-70. doi: 10.2176\/jns-nmc.2021-0382","DOI":"10.2176\/jns-nmc.2021-0382"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4) Liu W, Morito D, Takashima S, et al. Identification of RNF213 as a susceptibility gene for Moyamoya disease and its possible role in vascular development. PLoS One. 2011;6 (7):e22542. doi: 10.1371\/journal.pone.0022542","DOI":"10.1371\/journal.pone.0022542"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5) Kamada F, Aoki Y, Narisawa A, et al. A genome-wide association study identifies RNF213 as the first Moyamoya disease gene. J Hum Genet. 2011;56 (1):34-40. doi: 10.1038\/jhg.2010.132","DOI":"10.1038\/jhg.2010.132"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6) Kaku Y, Morioka M, Ohmori Y, et al. Outer-diameter narrowing of the internal carotid and middle cerebral arteries in Moyamoya disease detected on 3D constructive interference in steady-state MR image: is arterial constrictive remodeling a major pathogenesis? Acta Neurochir (Wien). 2012;154 (12):2151-7. doi: 10.1007\/s00701-012-1472-4","DOI":"10.1007\/s00701-012-1472-4"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7) Kuroda S, Kashiwazaki D, Akioka N, et al. Specific shrinkage of carotid forks in Moyamoya disease: a novel key finding for diagnosis. Neurol Med Chir (Tokyo). 2015;55 (10):796-804. doi: 10.2176\/nmc.oa.2015-0044","DOI":"10.2176\/nmc.oa.2015-0044"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8) Komiyama M, Ishiguro T, Nishikawa M, et al. Constructive interference in steady state imaging of Moyamoya disease. Neurol Med Chir (Tokyo). 2002;42 (1):11-6; discussion 17. doi: 10.2176\/nmc.42.11","DOI":"10.2176\/nmc.42.11"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9) Yamamoto S, Kashiwazaki D, Uchino H, et al. Stenosis severity-dependent shrinkage of posterior cerebral artery in Moyamoya disease. World Neurosurg. 2019;126:e661-70. doi: 10.1016\/j.wneu.2019.02.120","DOI":"10.1016\/j.wneu.2019.02.120"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10) Yamamoto S, Kashiwazaki D, Akioka N, et al. Progressive shrinkage of involved arteries in parallel with disease progression in Moyamoya disease. World Neurosurg. 2019;122:e253-61. doi: 10.1016\/j.wneu.2018.10.001","DOI":"10.1016\/j.wneu.2018.10.001"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11) Kuroda S, Fujimura M, Takahashi J, et al. Diagnostic criteria for Moyamoya disease - 2021 Revised Version. Neurol Med Chir (Tokyo). rev version. 2022;62 (7):307-12. doi: 10.2176\/jns-nmc.2022-0072","DOI":"10.2176\/jns-nmc.2022-0072"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12) Miyawaki S, Imai H, Takayanagi S, et al. Identification of a genetic variant common to Moyamoya disease and intracranial major artery stenosis\/occlusion. Stroke. 2012;43 (12):3371-4. doi: 10.1161\/STROKEAHA.112.663864","DOI":"10.1161\/STROKEAHA.112.663864"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Hongo H, Miyawaki S, Imai H, et al. Smaller outer diameter of atherosclerotic middle cerebral artery associated with RNF213 c.14576G&gt;A variant (rs112735431). Surg Neurol Int. 2017;8:104. doi: 10.4103\/sni.sni_59_17","DOI":"10.4103\/sni.sni_59_17"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14) Uchino H, Ito M, Kazumata K, et al. Circulating miRNome profiling in Moyamoya disease-discordant monozygotic twins and endothelial microRNA expression analysis using iPS cell line. BMC Med Genomics. 2018;11 (1):72. doi: 10.1186\/s12920-018-0385-3","DOI":"10.1186\/s12920-018-0385-3"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15) Fujimura M, Tominaga T. Lessons learned from Moyamoya disease: outcome of direct\/indirect revascularization surgery for 150 affected hemispheres. Neurol Med Chir (Tokyo). 2012;52 (5):327-32. doi: 10.2176\/nmc.52.327","DOI":"10.2176\/nmc.52.327"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Kuroda S, Houkin K. Moyamoya disease: current concepts and future perspectives. Lancet Neurol. 2008;7 (11):1056-66. doi: 10.1016\/S1474-4422 (08) 70240-0","DOI":"10.1016\/S1474-4422(08)70240-0"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17) Ryoo S, Cha J, Kim SJ, et al. High-resolution magnetic resonance wall imaging findings of Moyamoya disease. Stroke. 2014;45 (8):2457-60. doi: 10.1161\/STROKEAHA.114.004761","DOI":"10.1161\/STROKEAHA.114.004761"},{"key":"18","doi-asserted-by":"publisher","unstructured":"18) Fukui M, Kono S, Sueishi K, et al. Moyamoya disease. Neuropathology. 2000;20 (suppl):S61-4. doi: 10.1046\/j.1440-1789.2000.00300.x","DOI":"10.1046\/j.1440-1789.2000.00300.x"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19) Takagi Y, Kikuta K, Nozaki K, et al. Histological features of middle cerebral arteries from patients treated for Moyamoya disease. Neurol Med Chir (Tokyo). 2007;47 (1):1-4. doi: 10.2176\/nmc.47.1","DOI":"10.2176\/nmc.47.1"},{"key":"20","doi-asserted-by":"publisher","unstructured":"20) Takagi Y, Hermanto Y, Takahashi JC, et al. Histopathological characteristics of distal middle cerebral artery in adult and pediatric patients with Moyamoya disease. Neurol Med Chir (Tokyo). 2016;56 (6):345-9. doi: 10.2176\/nmc.oa.2016-0031","DOI":"10.2176\/nmc.oa.2016-0031"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Gibbons GH, Dzau VJ. The emerging concept of vascular remodeling. N Engl J Med. 1994;330 (20):1431-8. doi: 10.1056\/NEJM199405193302008","DOI":"10.1056\/NEJM199405193302008"},{"key":"22","doi-asserted-by":"publisher","unstructured":"22) Hitomi T, Habu T, Kobayashi H, et al. Downregulation of Securin by the variant RNF213 R4810K (rs112735431, G&gt;A) reduces angiogenic activity of induced pluripotent stem cell-derived vascular endothelial cells from moyamoya patients. Biochem Biophys Res Commun. 2013;438 (1):13-9. doi: 10.1016\/j.bbrc.2013.07.004","DOI":"10.1016\/j.bbrc.2013.07.004"},{"key":"23","doi-asserted-by":"publisher","unstructured":"23) Hamauchi S, Shichinohe H, Uchino H, et al. Cellular functions and gene and protein expression profiles in endothelial cells derived from Moyamoya disease-specific iPS cells. PLOS One. 2016;11 (9):e0163561. doi: 10.1371\/journal.pone.0163561","DOI":"10.1371\/journal.pone.0163561"},{"key":"24","doi-asserted-by":"publisher","unstructured":"24) Tokairin K, Hamauchi S, Ito M, et al. Vascular smooth muscle cell derived from IPS cell of Moyamoya disease - comparative characterization with endothelial cell transcriptome. J Stroke Cerebrovasc Dis. 2020;29 (12):105305. doi: 10.1016\/j.jstrokecerebrovasdis.2020.105305","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.105305"},{"key":"25","doi-asserted-by":"publisher","unstructured":"25) Ohkubo K, Sakai Y, Inoue H, et al. Moyamoya disease susceptibility gene RNF213 links inflammatory and angiogenic signals in endothelial cells. Sci Rep. 2015;5:13191. doi: 10.1038\/srep13191","DOI":"10.1038\/srep13191"},{"key":"26","doi-asserted-by":"publisher","unstructured":"26) Phi JH, Suzuki N, Moon YJ, et al. Chemokine ligand 5 (CCL5) derived from endothelial colony-forming cells (ECFCs) mediates recruitment of smooth muscle progenitor cells (SPCs) toward critical vascular locations in Moyamoya disease. PLOS One. 2017;12 (1):e0169714. doi: 10.1371\/journal.pone.0169714","DOI":"10.1371\/journal.pone.0169714"},{"key":"27","doi-asserted-by":"publisher","unstructured":"27) Bang OY, Chung JW, Kim SJ, et al. Caveolin-1, ring finger protein 213, and endothelial function in Moyamoya disease. Int J Stroke. 2016;11 (9):999-1008. doi: 10.1177\/1747493016662039","DOI":"10.1177\/1747493016662039"},{"key":"28","doi-asserted-by":"publisher","unstructured":"28) Chung JW, Kim DH, Oh MJ, et al. Cav-1 (Caveolin-1) and arterial remodeling in adult Moyamoya disease. Stroke. 2018;49 (11):2597-604. doi: 10.1161\/STROKEAHA.118.021888","DOI":"10.1161\/STROKEAHA.118.021888"},{"key":"29","doi-asserted-by":"publisher","unstructured":"29) Uchino H, Ito M, Tokairin K, et al. Association of RNF213 polymorphism and cortical hyperintensity sign on fluid-attenuated inversion recovery images after revascularization surgery for Moyamoya disease: possible involvement of intrinsic vascular vulnerability. Neurosurg Rev. 2023;46 (1):119. doi: 10.1007\/s10143-023-02030-3","DOI":"10.1007\/s10143-023-02030-3"},{"key":"30","doi-asserted-by":"publisher","unstructured":"30) Kawabori M, Ito M, Kazumata K, et al. Impact of RNF213 c.14576G&gt;A variant on the development of direct and indirect revascularization in pediatric Moyamoya disease. Cerebrovasc Dis. 2023;52 (2):171-6. doi: 10.1159\/000526089","DOI":"10.1159\/000526089"},{"key":"31","doi-asserted-by":"publisher","unstructured":"31) Ito M, Kawabori M, Sugiyama T, et al. Impact of RNF213 founder polymorphism (p.R4810K) on the postoperative development of indirect pial synangiosis after direct\/indirect combined revascularization surgery for adult Moyamoya disease. Neurosurg Rev. 2022;45 (3):2305-13. doi: 10.1007\/s10143-022-01749-9","DOI":"10.1007\/s10143-022-01749-9"}],"container-title":["Neurologia medico-chirurgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/nmc\/65\/6\/65_2025-0019\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T04:20:15Z","timestamp":1750479615000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/nmc\/65\/6\/65_2025-0019\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,15]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2176\/jns-nmc.2025-0019","relation":{},"ISSN":["0470-8105","1349-8029"],"issn-type":[{"value":"0470-8105","type":"print"},{"value":"1349-8029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,15]]},"article-number":"2025-0019"}}